Netherton syndrome (NS) is a severe skin disease caused by the loss of protease inhibitor LEKTI, which leads to the dysregulation of epidermal proteases and severe skin-barrier defects. KLK5 was proposed as a major protease in NS pathology, however its inactivation is not sufficient to rescue the lethal phenotype of LEKTI-deficient mice. In this study, we further elucidated the in vivo roles of the epidermal proteases in NS using a set of mouse models individually or simultaneously deficient for KLK5 and KLK7 on the genetic background of a novel NS-mouse model. We show that although the ablation of KLK5 or KLK7 is not sufficient to rescue the lethal effect of LEKTI-deficiency simultaneous deficiency of both KLKs completely rescues the epidermal barrier and the postnatal lethality allowing mice to reach adulthood with fully functional skin and normal hair growth. We report that not only KLK5 but also KLK7 plays an important role in the inflammation and defective differentiation in NS and KLK7 activity is not solely dependent on activation by KLK5. Altogether, these findings show that unregulated activities of KLK5 and KLK7 are responsible for NS development and both proteases should become targets for NS therapy.

Czech Centre for Phenogenomics Division BIOCEV Institute of Molecular Genetics of the Czech Academy of Sciences v v i Vestec Czech Republic

Department of Medical Biosciences Pathology Umea University Umea Sweden

Faculty of Sciences Charles University Prague Prague Czech Republic

Laboratory of Molecular Structure Characterization Institute of Microbiology of the Czech Academy of Sciences v v i Prague Czech Republic

Laboratory of Transgenic Models of Diseases Division BIOCEV Institute of Molecular Genetics of the Czech Academy of Sciences v v i Vestec Czech Republic

Zobrazit více v PubMed

Bitoun E, Chavanas S, Irvine AD, Lonie L, Bodemer C, et al. (2002) Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families. J Invest Dermatol 118: 352–361. 10.1046/j.1523-1747.2002.01603.x PubMed DOI

Furio L, Hovnanian A (2014) Netherton syndrome: defective kallikrein inhibition in the skin leads to skin inflammation and allergy. Biol Chem 395: 945–958. 10.1515/hsz-2014-0137 PubMed DOI

Sun JD, Linden KG (2006) Netherton syndrome: a case report and review of the literature. Int J Dermatol 45: 693–697. 10.1111/j.1365-4632.2005.02637.x PubMed DOI

Ito M, Ito K, Hashimoto K (1984) Pathogenesis in trichorrhexis invaginata (bamboo hair). J Invest Dermatol 83: 1–6. PubMed

Smith DL, Smith JG, Wong SW, deShazo RD (1995) Netherton's syndrome: a syndrome of elevated IgE and characteristic skin and hair findings. J Allergy Clin Immunol 95: 116–123. PubMed

Chavanas S, Bodemer C, Rochat A, Hamel-Teillac D, Ali M, et al. (2000) Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 25: 141–142. 10.1038/75977 PubMed DOI

Bitoun E, Micheloni A, Lamant L, Bonnart C, Tartaglia-Polcini A, et al. (2003) LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome. Hum Mol Genet 12: 2417–2430. 10.1093/hmg/ddg247 PubMed DOI

Fortugno P, Bresciani A, Paolini C, Pazzagli C, El Hachem M, et al. (2011) Proteolytic activation cascade of the Netherton syndrome-defective protein, LEKTI, in the epidermis: implications for skin homeostasis. J Invest Dermatol 131: 2223–2232. 10.1038/jid.2011.174 PubMed DOI

Bennett K, Callard R, Heywood W, Harper J, Jayakumar A, et al. (2010) New role for LEKTI in skin barrier formation: label-free quantitative proteomic identification of caspase 14 as a novel target for the protease inhibitor LEKTI. J Proteome Res 9: 4289–4294. 10.1021/pr1003467 PubMed DOI

Mitsudo K, Jayakumar A, Henderson Y, Frederick MJ, Kang Y, et al. (2003) Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis. Biochemistry 42: 3874–3881. 10.1021/bi027029v PubMed DOI

Jayakumar A, Kang Y, Mitsudo K, Henderson Y, Frederick MJ, et al. (2004) Expression of LEKTI domains 6–9' in the baculovirus expression system: recombinant LEKTI domains 6–9' inhibit trypsin and subtilisin A. Protein Expr Purif 35: 93–101. 10.1016/j.pep.2003.12.004 PubMed DOI

Egelrud T, Brattsand M, Kreutzmann P, Walden M, Vitzithum K, et al. (2005) hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6. Br J Dermatol 153: 1200–1203. 10.1111/j.1365-2133.2005.06834.x PubMed DOI

Schechter NM, Choi EJ, Wang ZM, Hanakawa Y, Stanley JR, et al. (2005) Inhibition of human kallikreins 5 and 7 by the serine protease inhibitor lympho-epithelial Kazal-type inhibitor (LEKTI). Biol Chem 386: 1173–1184. 10.1515/BC.2005.134 PubMed DOI

Deraison C, Bonnart C, Lopez F, Besson C, Robinson R, et al. (2007) LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction. Mol Biol Cell 18: 3607–3619. 10.1091/mbc.E07-02-0124 PubMed DOI PMC

Descargues P, Deraison C, Bonnart C, Kreft M, Kishibe M, et al. (2005) Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat Genet 37: 56–65. 10.1038/ng1493 PubMed DOI

Komatsu N, Takata M, Otsuki N, Ohka R, Amano O, et al. (2002) Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides. J Invest Dermatol 118: 436–443. 10.1046/j.0022-202x.2001.01663.x PubMed DOI

Descargues P, Deraison C, Prost C, Fraitag S, Mazereeuw-Hautier J, et al. (2006) Corneodesmosomal cadherins are preferential targets of stratum corneum trypsin- and chymotrypsin-like hyperactivity in Netherton syndrome. J Invest Dermatol 126: 1622–1632. 10.1038/sj.jid.5700284 PubMed DOI

Caubet C, Jonca N, Brattsand M, Guerrin M, Bernard D, et al. (2004) Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J Invest Dermatol 122: 1235–1244. 10.1111/j.0022-202X.2004.22512.x PubMed DOI

Sandilands A, Sutherland C, Irvine AD, McLean WH (2009) Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci 122: 1285–1294. 10.1242/jcs.033969 PubMed DOI PMC

Bonnart C, Deraison C, Lacroix M, Uchida Y, Besson C, et al. (2010) Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing. J Clin Invest 120: 871–882. 10.1172/JCI41440 PubMed DOI PMC

Sakabe J, Yamamoto M, Hirakawa S, Motoyama A, Ohta I, et al. (2013) Kallikrein-related peptidase 5 functions in proteolytic processing of profilaggrin in cultured human keratinocytes. J Biol Chem 288: 17179–17189. 10.1074/jbc.M113.476820 PubMed DOI PMC

Briot A, Lacroix M, Robin A, Steinhoff M, Deraison C, et al. (2010) Par2 inactivation inhibits early production of TSLP, but not cutaneous inflammation, in Netherton syndrome adult mouse model. J Invest Dermatol 130: 2736–2742. 10.1038/jid.2010.233 PubMed DOI

Briot A, Deraison C, Lacroix M, Bonnart C, Robin A, et al. (2009) Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J Exp Med 206: 1135–1147. 10.1084/jem.20082242 PubMed DOI PMC

Furio L, Pampalakis G, Michael IP, Nagy A, Sotiropoulou G, et al. (2015) KLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton Syndrome. PLoS Genet 11: e1005389 10.1371/journal.pgen.1005389 PubMed DOI PMC

Raghunath M, Tontsidou L, Oji V, Aufenvenne K, Schurmeyer-Horst F, et al. (2004) SPINK5 and Netherton syndrome: novel mutations, demonstration of missing LEKTI, and differential expression of transglutaminases. J Invest Dermatol 123: 474–483. 10.1111/j.0022-202X.2004.23220.x PubMed DOI

Yang T, Liang D, Koch PJ, Hohl D, Kheradmand F, et al. (2004) Epidermal detachment, desmosomal dissociation, and destabilization of corneodesmosin in Spink5-/- mice. Genes Dev 18: 2354–2358. 10.1101/gad.1232104 PubMed DOI PMC

Hewett DR, Simons AL, Mangan NE, Jolin HE, Green SM, et al. (2005) Lethal, neonatal ichthyosis with increased proteolytic processing of filaggrin in a mouse model of Netherton syndrome. Hum Mol Genet 14: 335–346. 10.1093/hmg/ddi030 PubMed DOI

Kasparek P, Ileninova Z, Haneckova R, Kanchev I, Jenickova I, et al. (2016) A viable mouse model for Netherton syndrome based on mosaic inactivation of the Spink5 gene. Biol Chem 397: 1287–1292. 10.1515/hsz-2016-0194 PubMed DOI

Skarnes WC, Rosen B, West AP, Koutsourakis M, Bushell W, et al. (2011) A conditional knockout resource for the genome-wide study of mouse gene function. Nature 474: 337–342. 10.1038/nature10163 PubMed DOI PMC

Chidgey M, Brakebusch C, Gustafsson E, Cruchley A, Hail C, et al. (2001) Mice lacking desmocollin 1 show epidermal fragility accompanied by barrier defects and abnormal differentiation. J Cell Biol 155: 821–832. 10.1083/jcb.200105009 PubMed DOI PMC

Leclerc EA, Huchenq A, Mattiuzzo NR, Metzger D, Chambon P, et al. (2009) Corneodesmosin gene ablation induces lethal skin-barrier disruption and hair-follicle degeneration related to desmosome dysfunction. J Cell Sci 122: 2699–2709. 10.1242/jcs.050302 PubMed DOI

Sales KU, Masedunskas A, Bey AL, Rasmussen AL, Weigert R, et al. (2010) Matriptase initiates activation of epidermal pro-kallikrein and disease onset in a mouse model of Netherton syndrome. Nat Genet 42: 676–683. 10.1038/ng.629 PubMed DOI PMC

Miyai M, Matsumoto Y, Yamanishi H, Yamamoto-Tanaka M, Tsuboi R, et al. (2014) Keratinocyte-specific mesotrypsin contributes to the desquamation process via kallikrein activation and LEKTI degradation. J Invest Dermatol 134: 1665–1674. 10.1038/jid.2014.3 PubMed DOI

Bhogal RK, Mouser PE, Higgins CA, Turner GA (2014) Protease activity, localization and inhibition in the human hair follicle. Int J Cosmet Sci 36: 46–53. 10.1111/ics.12091 PubMed DOI PMC

Kljuic A, Bazzi H, Sundberg JP, Martinez-Mir A, O'Shaughnessy R, et al. (2003) Desmoglein 4 in hair follicle differentiation and epidermal adhesion: evidence from inherited hypotrichosis and acquired pemphigus vulgaris. Cell 113: 249–260. PubMed

Montagutelli X, Hogan ME, Aubin G, Lalouette A, Guenet JL, et al. (1996) Lanceolate hair (lah): a recessive mouse mutation with alopecia and abnormal hair. J Invest Dermatol 107: 20–25. PubMed

Alibardi L, Tschachler E, Eckhart L (2005) Distribution of caspase-14 in epidermis and hair follicles is evolutionarily conserved among mammals. Anat Rec A Discov Mol Cell Evol Biol 286: 962–973. 10.1002/ar.a.20234 PubMed DOI

Hansson L, Backman A, Ny A, Edlund M, Ekholm E, et al. (2002) Epidermal overexpression of stratum corneum chymotryptic enzyme in mice: a model for chronic itchy dermatitis. J Invest Dermatol 118: 444–449. 10.1046/j.0022-202x.2001.01684.x PubMed DOI

Ny A, Egelrud T (2004) Epidermal hyperproliferation and decreased skin barrier function in mice overexpressing stratum corneum chymotryptic enzyme. Acta Derm Venereol 84: 18–22. PubMed

Walker F, Nicole P, Jallane A, Soosaipillai A, Mosbach V, et al. (2014) Kallikrein-related peptidase 7 (KLK7) is a proliferative factor that is aberrantly expressed in human colon cancer. Biol Chem 395: 1075–1086. 10.1515/hsz-2014-0142 PubMed DOI

Stefansson K, Brattsand M, Roosterman D, Kempkes C, Bocheva G, et al. (2008) Activation of proteinase-activated receptor-2 by human kallikrein-related peptidases. J Invest Dermatol 128: 18–25. 10.1038/sj.jid.5700965 PubMed DOI

Nylander-Lundqvist E, Egelrud T (1997) Formation of active IL-1 beta from pro-IL-1 beta catalyzed by stratum corneum chymotryptic enzyme in vitro. Acta Derm Venereol 77: 203–206. PubMed

Cermak T, Doyle EL, Christian M, Wang L, Zhang Y, et al. (2011) Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res 39: e82 10.1093/nar/gkr218 PubMed DOI PMC

Doyle EL, Booher NJ, Standage DS, Voytas DF, Brendel VP, et al. (2012) TAL Effector-Nucleotide Targeter (TALE-NT) 2.0: tools for TAL effector design and target prediction. Nucleic Acids Res 40: W117–122. 10.1093/nar/gks608 PubMed DOI PMC

Flemr M, Malik R, Franke V, Nejepinska J, Sedlacek R, et al. (2013) A retrotransposon-driven dicer isoform directs endogenous small interfering RNA production in mouse oocytes. Cell 155: 807–816. 10.1016/j.cell.2013.10.001 PubMed DOI

Kasparek P, Krausova M, Haneckova R, Kriz V, Zbodakova O, et al. (2014) Efficient gene targeting of the Rosa26 locus in mouse zygotes using TALE nucleases. FEBS Lett 588: 3982–3988. 10.1016/j.febslet.2014.09.014 PubMed DOI

Kasparek P, Krenek P, Buryova H, Suchanova S, Beck IM, et al. (2012) Transgenic mouse model expressing tdTomato under involucrin promoter as a tool for analysis of epidermal differentiation and wound healing. Transgenic Res 21: 683–689. 10.1007/s11248-011-9567-x PubMed DOI

Sondell B, Dyberg P, Anneroth GK, Ostman PO, Egelrud T (1996) Association between expression of stratum corneum chymotryptic enzyme and pathological keratinization in human oral mucosa. Acta Derm Venereol 76: 177–181. PubMed

Rescuing lethal phenotypes induced by disruption of genes in mice: a review of novel strategies

Differential regulation of vaginal lipocalins (OBP, MUP) during the estrous cycle of the house mouse

On the tear proteome of the house mouse (Mus musculus musculus) in relation to chemical signalling